Sort
141,003 grants matching “cytokine”
Cell-free assay technologies for the identification of active compounds
$857,347Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Metabolite- and cytokine-mediated signals interact to control human CD8 T cell responses in tissues
$857,346Martin Prlic · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Influenza pathogenesis in pregnancy
$857,164Kristina M Adams Waldorf · University Of Washington · R01 · FY2023 · AI
AsthmaNet: Phenotypic Influences on Asthma Treatments
$857,131Sally E Wenzel · University Of Pittsburgh At Pittsburgh · U10 · FY2011 · HL
TAM Receptors and Virus Infection
$857,077Greg E Lemke · Salk Institute For Biological Studies · R01 · FY2017 · AI
Safety and Efficacy of Itacitinib in treatment of JAK/STAT pathway disorders with activating mutations
$857,021Lisa Forbes · Baylor College Of Medicine · UH3 · FY2025 · TR
Understanding HIV-1 persistence in cytotoxic CD4+ T lymphocytes at the single cell level
$856,949Ya-Chi Ho · Yale University · R01 · FY2023 · AI
Defining the Role of ANKEF1 in Ciliary Function and Host Defense Against Influenza Virus Infection
$856,791Lisa Miorin · Icahn School Of Medicine At Mount Sinai · R56 · FY2025 · AI
Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis
$856,782Chad Allen Koplinski · Xlock Biosciences, Llc · R44 · FY2020 · AR
Quantitative measurement of T1D risk through molecular signature analysis
$856,742Martin John Hessner · Medical College Of Wisconsin · DP3 · FY2013 · DK
Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD
$856,728Defu Zeng · Beckman Research Institute/City Of Hope · R01 · FY2025 · HL
Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD
$856,728Defu Zeng · Beckman Research Institute/City Of Hope · R01 · FY2023 · HL
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites
$856,521Joshua Tisdell Schiffer · Fred Hutchinson Cancer Research Center · R01 · FY2016 · AI
Regulation of host innate and adaptive immunity by bacterial type III effectors
$856,414James B Bliska · Dartmouth College · R01 · FY2025 · AI
Preventing GVHD by inhibition of alloantigen presentation in the gut
$856,395Geoffrey Roger Hill · Fred Hutchinson Cancer Center · R01 · FY2023 · HL
Immune Basis of FPIES
$856,323Maria Cecilia Berin · Northwestern University At Chicago · U01 · FY2022 · AI
STudy of Acute HIV for investiGating Eradication Strategies (STAGES): The role of IL-10 and IFN signaling
$856,202Sulggi Angela Lee · University Of California, San Francisco · R01 · FY2025 · AI
Membrane protein target for leukemia therapy
$855,881Xunlei Kang · University Of Missouri-Columbia · R37 · FY2025 · CA
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma
$855,867Sally E Wenzel · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · HL
Pathogenesis of HIV and HCV in Hemophilia: HGDS
$855,816Children'S Hospital Los Angeles · R01 · FY2001 · HD
Gene Transfer into Hematopoietic Stem Cells
$855,768Fabio Candotti · National Human Genome Research Institute · Z01 · FY2008 · HG
Biomarker Investigations for Clinical Trials
$855,747Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Angiogenesis and Tumor Growth
$855,728Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Role of cellular senescence in cardiovascular aging
$855,648Simon Melov · Buck Institute For Research On Aging · R01 · FY2021 · AG
Maximizing Efficacy of Goal-Directed Sedation to Reduce Neurological Dysfunction in Mechanically Ventilated Infants and Children Study (mini-MENDS)
$855,283Heidi A B Smith · Vanderbilt University Medical Center · R61 · FY2020 · HL